Baseline Productions (BSSP) Stock Price

Baseline Productions Price

NYSE·CLOSED
0.00
​
Market closed

Baseline Productions stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Baseline Productions business model & stock analysis

Baseline Productions Inc develops mobile based hardware and software based products. The company focuses on commercialization of its proteins for cancer and infectious disease treatments. Its Irreversible Pepsin Fraction (IPF) technology activates the immune system to fight autoimmune diseases. IPF binds to T-cells and triggers Th1 responses that eliminate infected cells. The firm's lead compound is an IPF suspension for autoimmune disease treatment including cancer, cirrhosis, and Hepatitis C. The product IMMUNE-THERAPEUTIC PROTEIN (ITP) is a therapeutic protein derived from porcine pepsin, which is irreversible, modified, and fractionated to IPF sequence. The company sells its IPF platform technology and ITP product to healthcare providers and pharmaceutical companies. Healthcare providers use IPF for immune system activation in autoimmune disease treatment. Pharmaceutical companies purchase ITP for development into therapeutic applications. The target segments include medical institutions treating autoimmune conditions and drug manufacturers seeking novel protein-based therapies. ITP is specifically indicated for cancer, cirrhosis, and Hepatitis C treatment. Baseline Productions generates revenue through licensing IPF technology and selling ITP therapeutic protein. The IPF platform is sold as a technology solution to partners in the healthcare sector. ITP is marketed as a therapeutic product for direct sale to medical facilities. The company's primary customers are healthcare institutions and pharmaceutical firms interested in immune system-based treatments for autoimmune diseases and infectious conditions.

Frequently asked questions about Baseline Productions

Converted at the current exchange rate, the Baseline Productions share trades at 0.00 EUR (0.00 USD).

The revenue cannot currently be calculated for Baseline Productions.

The profit cannot currently be calculated for Baseline Productions.

The P/E ratio cannot be calculated for Baseline Productions at the moment.

The P/S cannot be calculated for Baseline Productions currently.

The Eulerpool Quality Score for Baseline Productions is 1/10.

The ISIN of Baseline Productions is US0702491079. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Baseline Productions is BSSP. The ticker symbol is used to trade Baseline Productions shares on the stock exchange.

Fair ValueTerminal
0.00 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Biotechnology
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website
Currency
USD
Initial public offering
Sep 28, 2011
ISIN
US0702491079
Cusip
070249107
Market capitalization
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
—
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
6.40 %
Last updated Nov 10, 2026, 3:51 AM

Baseline Productions Peer Group

Baseline Productions FIGI

BSSP:US · BBG001NMK7C2BSSP:PQ · BBG001NMK7S5BSSP:UV · BBG001NMK7V1